Svetlana Nikic, Founder of Precision Oncology Consulting, shared a post on LinkedIn:
“48h to go for our Live Discussion on Heterogenous healthcare systems across Europe and its impact on reimbursement of innovative cancer diagnostics!
- Wednesday, October 29
- 17:00 CET
If this is relevant to your work in oncology diagnostics and market access, please join and share with your network.
Also, do participate in the post below. I would love to hear from you on what type of evidence shifts the payer discussions most effectively.”
More posts featuring Svetlana Nikic on OncoDaily.
![[LIVE] February 10, 2026: Bitcoin and Crypto News — Daily Highlights](https://foundernews.eu/storage/2026/02/v2u4URy9S4aLs7Yq0yiuuw.png)
Leave a Reply